M&A Deal Summary |
|
---|---|
Date | 2015-09-09 |
Target | NeuroFix Therapeutics |
Sector | Life Science |
Buyer(s) | Aevi Genomic Medicine |
Deal Type | Add-on Acquisition |
Deal Value | 2M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2000 |
Sector | Life Science |
Employees | 14 |
Aevi Genomic Medicine, Inc. is a biopharmaceutical company developing a technology platform for the purpose of treating patients with rare and orphan diseases. Driven by a commitment to patients with pediatric-onset life-altering diseases, Aevi’s research and development efforts include working with the Center for Applied Genomics (CAG) at Children’s Hospital of Philadelphia to leverage novel genetic discoveries to progress its genomic medicine strategy. Aevi Genomic Medicine was founded in 2000 and is based in Wayne, Pennsylvania.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Life Science) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (United States) | 1 of 1 |
Year (2015) | 1 of 1 |
Size (of disclosed) | 1 of 1 |